Talkspace, Inc. (TALK)
NASDAQ:TALK
Want to see TALK full AI Analyst Report?
TALK Stock Chart & Stats
$5.18
-$0.06(-1.90%)
At close: 4:00 PM EST
$5.18
-$0.06(-1.90%)
Day’s Range― - ―
52-Week Range$2.22 - $5.20
Previous CloseN/A
Volume269.09K
Average Volume (3M)1.43M
Market Cap
$871.07M
Enterprise Value$839.65M
Total Cash (Recent Filing)$84.21M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.05
Next Earnings
Aug 10, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding167,512,570
10 Day Avg. Volume1,486,105
30 Day Avg. Volume1,429,252
Financial Highlights & Ratios
PEG Ratio0.13
Price to Book (P/B)5.22
Price to Sales (P/S)2.67
P/FCF Ratio-290.17
Enterprise Value/Market Cap0.96
Enterprise Value/Revenue3.52
Enterprise Value/Gross Profit8.34
Enterprise Value/Ebitda135.49
Forecast
1Y Price Target
$5.25Price Target Upside1.35% Upside
Rating ConsensusHold
Number of Analyst Covering6
EPS Forecast (FY)0.14
Revenue Forecast (FY)$282.24M
Bulls Say, Bears Say
Bulls Say
Payor Integrations And UtilizationDeeper integrations with insurance portals reduce sign-up friction and drive higher session bookings, which can boost utilization among insured lives and support sustained revenue growth.
Proprietary AI Product PotentialPlanned HIPAA-compliant, clinician-reviewed AI agent trained on proprietary clinical data could open a recurring revenue stream and attract users to therapist-led care, offering upside beyond current estimates.
Strategic Acquisition And ScaleAcquisition provides immediate national virtual care scale and diversifies revenue by adding a large outpatient mental health platform, creating synergies that can fill clinician schedules and strengthen growth prospects.
Bears Say
Deal Limits Standalone UpsideAnnounced transaction and the agreed price largely price in the company's strategic value, which can limit upside for shareholders and reduce the appeal of the stock as a standalone investment.
Execution And Cash Flow Pressures From AI And Consumer ChannelsIncreased spending to develop proprietary AI models combined with higher customer acquisition costs in direct-to-consumer channels has pressured cash generation and could weigh on margins if demand and reimbursement conditions stay weak.
Shareholder Return ConcernsSuspension of share repurchases removes a source of shareholder support and raises questions about near-term capital allocation and returns.
Talkspace News
TALK FAQ
What was Talkspace, Inc.’s price range in the past 12 months?
Talkspace, Inc. lowest stock price was $2.22 and its highest was $5.20 in the past 12 months.
What is Talkspace, Inc.’s market cap?
Talkspace, Inc.’s market cap is $871.07M.
When is Talkspace, Inc.’s upcoming earnings report date?
Talkspace, Inc.’s upcoming earnings report date is Aug 10, 2026 which is in 76 days.
How were Talkspace, Inc.’s earnings last quarter?
Talkspace, Inc. released its earnings results on May 05, 2026. The company reported -$0.038 earnings per share for the quarter, missing the consensus estimate of $0.021 by -$0.059.
Is Talkspace, Inc. overvalued?
According to Wall Street analysts Talkspace, Inc.’s price is currently Undervalued.
Does Talkspace, Inc. pay dividends?
Talkspace, Inc. does not currently pay dividends.
What is Talkspace, Inc.’s EPS estimate?
Talkspace, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Talkspace, Inc. have?
Talkspace, Inc. has 167,512,570 shares outstanding.
What happened to Talkspace, Inc.’s price movement after its last earnings report?
Talkspace, Inc. reported an EPS of -$0.038 in its last earnings report, missing expectations of $0.021. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Talkspace, Inc.?
Currently, no hedge funds are holding shares in TALK
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Talkspace Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$5.25 (1.35% Upside)
$5.25 (1.35% Upside)
Blogger Sentiment
Bullish
TALK Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 1.5M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.0%
Last 30 Days ▼ 8.7%
Last 30 Days ▼ 8.7%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
88.40%
12-Months-Change
Fundamentals
Return on Equity
1.03%
Trailing 12-Months
Asset Growth
1.45%
Trailing 12-Months
Company Description
Talkspace, Inc.
Talkspace, Inc. operates as a virtual behavior healthcare company. It delivers healthcare through encrypted web and mobile platform. The company offers treatment options for every need, including psychiatry or adolescent, individual, or couples therapy. The members can send text, video, and voice messages to their therapists and engage in live video sessions. Talkspace, Inc. is based in New York, New York.
TALK Company Deck
TALK Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presents strong top-line growth, accelerated Payor traction, significant adjusted EBITDA expansion and operational improvements, supported by product innovation (AI, Talkcast, psychiatry expansion) and M&A (Wisdo). There are manageable execution risks: near-term gross margin pressure from mix, reduced cash after buybacks and acquisition, deliberate de-emphasis of Consumer revenue, and uncertainty around TalkAI commercialization and Medicare penetration. Overall, the positives — recurring Payor growth, margin expansion, and confident 2026 guidance — materially outweigh the listed challenges.View all TALK earnings summariesTALK Stock 12 Month Forecast
Average Price Target
$5.25
▲(1.35% Upside)
Technical Analysis
Acadia Healthcare
―
Cross Country Healthcare
―
Pediatrix Medical Group
―
COMPASS Pathways
―
Lifestance Health Group
―
Ownership Overview
19.02% Insiders
14.17% Mutual Funds
27.53% Other Institutional Investors
28.82% Public Companies and
Individual Investors